GLF
ABBV icon

Groupe la Francaise’s AbbVie ABBV Stock Holding History

Groupe la Francaise’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.1M Buy
193,380
+73,045
+61% +$16.2M 0.58% 39
2025
Q4 		$27.5M Buy
120,335
+93,289
+345% +$21.3M 0.39% 51
2025
Q3 		$6.16M Buy
27,046
+1,670
+7% +$340K 0.08% 139
2025
Q2 		$4.69M Buy
25,376
+6,466
+34% +$1.2M 0.08% 155
2025
Q1 		$3.83M Buy
18,910
+2,344
+14% +$456K 0.08% 160
2024
Q4 		$2.93M Buy
+16,566
New +$3.05M 0.07% 157

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Groupe la Francaise's ABBV Position: Q1 2026 in Review

Groupe la Francaise increased its AbbVie (ABBV) stake by 61% in Q1 2026, buying an estimated $16.2M and bringing the position to 193,380 shares worth $42.1M. The position accounts for 0.58% of the portfolio, ranked #39.

Groupe la Francaise first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. 4,097 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Groupe la Francaise held 193,380 shares of AbbVie worth $42.1M as of Q1 2026.
  • Groupe la Francaise bought 73,045 AbbVie shares in Q1 2026, an estimated $16.2M.
  • AbbVie made up 0.58% of Groupe la Francaise's portfolio in Q1 2026, its #39 holding.
  • Groupe la Francaise first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • 4,097 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.